Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Acosta

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Cell Death & Disease|March 25, 2026
Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector functionLuisina Inés Onofrio, Carolina Abrate, Ingrid Strusberg, et al.
Frontiers in Immunology|April 16, 2019
Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During <i>Trypanosoma cruzi</i> InfectionLaura Fernanda Ambrosio, Constanza Insfran, Ximena Volpini, et al.
Research Square|November 24, 2025
Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector functionLuisina Inés Onofrio, Carolina Abrate, Ingrid Strusberg, et al.
Journal of Hypertension|June 9, 2017
Twenty-four-hour central blood pressure is not better associated with hypertensive target organ damage than 24-h peripheral blood pressureAlejandro de la Sierra, Julia Pareja, Patricia Fernández-Llama, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 26, 2018
Central blood pressure variability is increased in hypertensive patients with target organ damageAlejandro de la Sierra, Julia Pareja, Sergi Yun, et al.
Plos Pathogens|January 5, 2019
Thymic expression of IL-4 and IL-15 after systemic inflammatory or infectious Th1 disease processes induce the acquisition of "innate" characteristics during CD8+ T cell developmentNatalia S Baez, Fabio Cerbán, Constanza Savid-Frontera, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Cell Death & Disease|March 25, 2026
Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector functionLuisina Inés Onofrio, Carolina Abrate, Ingrid Strusberg, et al.
Frontiers in Immunology|April 16, 2019
Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During <i>Trypanosoma cruzi</i> InfectionLaura Fernanda Ambrosio, Constanza Insfran, Ximena Volpini, et al.
Research Square|November 24, 2025
Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector functionLuisina Inés Onofrio, Carolina Abrate, Ingrid Strusberg, et al.
Journal of Hypertension|June 9, 2017
Twenty-four-hour central blood pressure is not better associated with hypertensive target organ damage than 24-h peripheral blood pressureAlejandro de la Sierra, Julia Pareja, Patricia Fernández-Llama, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 26, 2018
Central blood pressure variability is increased in hypertensive patients with target organ damageAlejandro de la Sierra, Julia Pareja, Sergi Yun, et al.
Plos Pathogens|January 5, 2019
Thymic expression of IL-4 and IL-15 after systemic inflammatory or infectious Th1 disease processes induce the acquisition of "innate" characteristics during CD8+ T cell developmentNatalia S Baez, Fabio Cerbán, Constanza Savid-Frontera, et al.
Pageof 5